Vanguard Personalized Indexing Management, LLC
Position in EDIT — Editas Medicine, Inc.
CIK 1767306
OAKLAND, CA
Position in EDIT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$124,108
+$26,109 QoQ
Shares Held
38,305
-3.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 216 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $98,300,353 across 139 Biotechnology names. EDIT ranks #92 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,151 | $21,434,396 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,712 | $7,302,900 | |
| 3 | INCY |
Incyte Corp
|
34,556 | $3,917,268 | |
| 4 | ARGX |
Argenx SE
|
4,103 | $3,806,640 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,436 | $3,442,579 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,697 | $3,314,294 | |
| 7 | MRNA |
Moderna, Inc.
|
43,679 | $3,058,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
30,414 | $2,380,503 |
All Filings in EDIT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,108 | 38,305 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $97,999 | 39,676 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $84,140 | 41,044 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $142,422 | 41,044 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $91,005 | 41,366 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $30,857 | 26,601 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,422 | 10,569 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $45,216 | 13,260 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||